International Medicine and Health Guidance News ›› 2025, Vol. 31 ›› Issue (20): 3389-3395.DOI: 10.3760/cma.j.cn441417-20250410-20010
• New Medical Advances • Previous Articles Next Articles
Research progress on mechanism of roles of lncRNA in esophageal cancer
					
													 
	Lin Yuning, Xie Hongyan, Zhao Wenzhen, Zhang Zhongying, Jin Hongwei
												  
						
						
						
					
Medical Laboratory, Xiamen Humanity Hospital, Xiamen 361000, China
Received:2025-04-10
															
							
															
							
															
							
																	Online:2025-10-15
															
							
																	Published:2025-10-27
															
						Contact:
								Zhang Zhongying, Email: zhangzy1121@xmu.edu.cn; Jin Hongwei, Email: jinhw@haxm.com   
													Supported by:Xiamen Natural Science Foundation (3502Z20227389)
lncRNA在食管癌中的作用机制研究进展
        
               		 
	林宇宁  谢鸿燕  赵文镇  张忠英  金宏伟
                  
        
        
        
        
厦门弘爱医院医学检验中心,厦门 361000
通讯作者:
					张忠英,Email:zhangzy1121@xmu.edu.cn;金宏伟,Email:jinhw@haxm.com
							基金资助:厦门市自然科学基金(3502Z20227389)
Lin Yuning, Xie Hongyan, Zhao Wenzhen, Zhang Zhongying, Jin Hongwei.
Research progress on mechanism of roles of lncRNA in esophageal cancer [J]. International Medicine and Health Guidance News, 2025, 31(20): 3389-3395.
林宇宁 谢鸿燕 赵文镇 张忠英 金宏伟.
lncRNA在食管癌中的作用机制研究进展 [J]. 国际医药卫生导报, 2025, 31(20): 3389-3395.
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.imhgn.com/EN/10.3760/cma.j.cn441417-20250410-20010
|   [1] Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3):229-263. DOI: 10.3322/caac.21834. [2] Teng Y, Xia C, Cao M, et al. Esophageal cancer global burden profiles, trends, and contributors[J]. Cancer Biol Med, 2024, 21(8):656–666. DOI: 10.20892/j.issn.2095-3941.2024.0145. [3] Yokoyama A, Kakiuchi N, Yoshizato T, et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers[J]. Nature, 2019, 565(7739):312-317. DOI: 10.1038/s41586-018-0811-x. [4] Zhuang P, Wu F, Liu X, et al. Preserved vegetable consumption and its association with mortality among 440,415 people in the China Kadoorie Biobank[J]. BMC Med, 2023, 21(1):135. DOI: 10.1186/s12916-023-02829-3. [5] 张嫣然,宇传华,胡迪,等. 1990-2019年中国归因于水果摄入不足的食管癌死亡趋势[J]. 中华疾病控制杂志,2023,27(1):4-10. DOI:10.16462/j.cnki.zhjbkz.2023.01.002. [6] Wong MCS, Deng Y, Huang J, et al. Performance of screening tests for esophageal squamous cell carcinoma: a systematic review and meta-analysis[J]. Gastrointest Endosc, 2022, 96(2):197-207.e34. DOI: 10.1016/j.gie.2022.04.005. [7] Min Q, Zhang M, Lin D, et al. Genomic characterization and risk stratification of esophageal squamous dysplasia [J]. Med Rev (2021), 2024, 4(3): 244-256. DOI: 10.1515/mr-2024-0008. [8] Vassilenko V, Moura PC, Raposo M. Diagnosis of carcinogenic pathologies through breath biomarkers: present and future trends[J]. Biomedicines, 2023, 11(11): 3029. DOI: 10.3390/biomedicines11113029. [9] 冯绪梅,宋相庆,季冠虹,等. 血浆外泌体miR-548k在食管鳞癌中的表达及诊断价值[J]. 山东大学学报(医学版),2024,62(5):79-88. DOI: 10.6040/j.issn.1671-7554.0.2024.0134. [10] Wang X, Yu N, Cheng G, et al. Prognostic value of circulating tumour DNA during post-radiotherapy surveillance in locally advanced esophageal squamous cell carcinoma[J]. Clin Transl Med, 2022,12(11): e1116. DOI: 10.1002/ctm2.1116. [11] 赵文镇,林宇宁. LINC01836是一种新的结直肠癌诊断和预后的生物标志物[J]. 国际医药卫生导报,2022,28(3):363-367. DOI: 10.3760/cma.j.issn.1007-1245.2022.03.017. [12] 蔡灿锋,李锦宏,辛海洋,等. 直肠癌新辅助放化疗疗效lncRNA分子预测模型构建[J]. 国际医药卫生导报,2024,30(19):3170-3175. DOI:10.3760/cma.j.issn.1007-1245.2024.19.001. [13] Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function[J]. J Cell Biol, 2021, 220(2):e202009045. DOI: 10.1083/jcb.202009045. [14] Fu H, Wang T, Kong X, et al. A nodal enhanced micropeptide NEMEP regulates glucose uptake during mesendoderm differentiation of embryonic stem cells[J]. Nat Commun, 2022,13(1):3984. DOI: 10.1038/s41467-022-31762-x. [15] Jia J, Li H, Chu J, et al. LncRNA FAM83A-AS1 promotes ESCC progression by regulating miR-214/CDC25B axis[J]. J Cancer, 2021, 12(4):1200-1211. DOI: 10.7150/jca.54007. [16] Han B, Ma Y, Yang P, et al. Novel histone acetylation-related lncRNA signature for predicting prognosis and tumor microenvironment in esophageal carcinoma[J]. Aging (Albany NY), 2024, 16(6):5163-5183. DOI: 10.18632/aging.205636. [17] Chen MJ, Deng J, Chen C, et al. LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis[J]. Int J Biochem Cell Biol, 2019, 113:27-36. DOI: 10.1016/j.biocel.2019.05.011. [18] 秦玉萍,曹通,许颖,等.敲低lncRNA CACNA1C-AS2促进上皮间质转化增强人食管癌细胞的增殖、侵袭和迁移[J].细胞与分子免疫学杂志,2023,39(3):249-257. [19] Xu J, Liu X, Liu X, et al. noncoding RNA KCNMB2-AS1 promotes the development of esophageal cancer by modulating the miR-3194-3p/PYGL axis[J]. Bioengineered, 2021, 12(1):6687-6702. DOI: 10.1080/21655979.2021.1973775. [20] Wang J, Zhang Z, Song L, et al. Inhibition of esophageal squamous cell carcinoma progression by MIR210HG and activation of the P53 signaling pathway to promote apoptosis and autophagy[J]. Eur J Med Res, 2025, 30(1):269. DOI: 10.1186/s40001-025-02512-8. [21] Tuersong T, Shataer M, Chen Y, et al. Extracellular vesicle-lncRNA HOTAIR modulates esophageal cancer chemoresistance and immune microenvironment via miR-375/CDH2 pathway[J]. J Cell Commun Signal, 2025, 19(2): e70014. DOI: 10.1002/ccs3.70014. [22] Plath K, Fang J, Mlynarczyk-Evans SK, et al. Role of histone H3 lysine 27 methylation in X inactivation[J]. Science, 2003, 300(5616):131-135. DOI: 10.1126/science.1084274. [23] Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals[J]. Nature, 2009,458(7235):223-227. DOI: 10.1038/nature07672. [24] Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs[J]. Cell, 2007, 129(7):1311-1323. DOI: 10.1016/j.cell.2007.05.022. [25] Rinn JL, Chang HY. Genome regulation by long noncoding RNAs[J]. Annu Rev Biochem, 2012,81:145-66. DOI: 10.1146/annurev-biochem-051410-092902. [26] Ao YQ, Gao J, Jiang JH, et al. Comprehensive landscape and future perspective of long noncoding RNAs in non-small cell lung cancer: it takes a village[J]. Mol Ther, 2023, 31(12):3389-3413. DOI: 10.1016/j.ymthe.2023.09.015. [27] Huarte M. The emerging role of lncRNAs in cancer[J]. Nat Med, 2015, 21(11): 1253-1261. DOI: 10.1038/nm.3981. [28] Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways [J]. Cancer Cell, 2016, 29(4): 452-463. DOI: 10.1016/j.ccell.2016.03.010. [29] Bhan A, Mandal SS. Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease[J]. ChemMedChem, 2014, 9(9):1932-1956. DOI: 10.1002/cmdc.201300534. [30] Chen Z, Tang W, Ye W, et al. ADAMTS9-AS2 regulates PPP1R12B by adsorbing miR-196b-5p and affects cell cycle-related signaling pathways inhibiting the malignant process of esophageal cancer[J]. Cell Cycle, 2022, 21(16): 1710-1725. DOI: 10.1080/15384101.2022.2067675. [31] Wu J, Liu Y, Huang X, et al. LncRNA DGCR5 silencing enhances the radio-sensitivity of human esophageal squamous cell carcinoma via negatively regulating the warburg effect[J]. Radiat Res, 2023, 199(3): 264-272. DOI: 10.1667/RADE-22-00126.1. [32] Liu JQ, Deng M, Xue NN, et al. lncRNA KLF3-AS1 suppresses cell migration and invasion in ESCC by impairing miR-185-5p-targeted KLF3 inhibition [J]. Mol Ther Nucleic Acids, 2020, 20: 231-241. DOI: 10.1016/j.omtn.2020.01.020. [33] Chen L, Lu J, Li X, et al. LncRNA KTN1-AS1 facilitates esophageal squamous cell carcinoma progression via miR-885-5p/STRN3 axis[J]. Genes Genomics, 2024, 46(2): 241-252. DOI: 10.1007/s13258-023-01451-0. [34] Zhong YB, Shan AJ, Lv W, et al. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma[J]. Eur Rev Med Pharmacol Sci, 2018, 22(23): 8288-8297. DOI: 10.26355/eurrev_201812_16526. [35] Li P, Ding H, Han S, et al. Long noncoding RNA LINC00858 aggravates the progression of esophageal squamous cell carcinoma via regulating the miR-425-5p/ABL2 axis[J]. Heliyon, 2024,10(6): e27337. DOI: 10.1016/j.heliyon.2024.e27337. [36] Hu D, Ma A, Lu H, et al. LINC00963 promotes cisplatin resistance in esophageal squamous cell carcinoma by interacting with miR-10a to upregulate SKA1 expression[J]. Appl Biochem Biotechnol, 2024, 196(10):7219-7232. DOI: 10.1007/s12010-024-04897-4. [37] Zhao F, Tian H, Wang Y, et al. LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma[J]. Cancer Immunol Immunother, 2023, 72(6):1835-1851. DOI: 10.1007/s00262-022-03364-5. [38] Liang F, Luo Q, Han H, et al. Long noncoding RNA LINC01088 inhibits esophageal squamous cell carcinoma progression by targeting the NPM1-HDM2-p53 axis[J]. Acta Biochim Biophys Sin (Shanghai), 2023, 55(3):367-381. DOI: 10.3724/abbs.2023021. [39] Zhang Y, Miao Y, Shang M, et al. LincRNA-p21 leads to G1 arrest by p53 pathway in esophageal squamous cell carcinoma[J]. Cancer Manag Res, 2019,11:6201-14. DOI: 10.2147/cmar.S197557. [40] Xiao Y, Tang J, Yang D, et al. Long noncoding RNA LIPH-4 promotes esophageal squamous cell carcinoma progression by regulating the miR-216b/IGF2BP2 axis[J]. Biomark Res, 2022, 10(1):60. DOI: 10.1186/s40364-022-00408-x. [41] Cheng W, Shi X, Lin M, et al. LncRNA MAGI2-AS3 overexpression sensitizes esophageal cancer cells to irradiation through down-regulation of HOXB7 via EZH2[J]. Front Cell Dev Biol, 2020, 8:552822. DOI: 10.3389/fcell.2020.552822. [42] Zhang S, Zhong J, Guo D, et al. MIAT shuttled by tumor-secreted exosomes promotes paclitaxel resistance in esophageal cancer cells by activating the TAF1/SREBF1 axis[J]. J Biochem Mol Toxicol, 2023, 37(8): e23380. DOI: 10.1002/jbt.23380. [43] Chu J, Li H, Xing Y, et al. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis[J]. Biomed Pharmacother, 2019, 116: 109029. DOI: 10.1016/j.biopha.2019.109029. [44] Wang Y, Wang Y, Zhang J, et al. LncRNA NONHSAT227443.1 confers esophageal squamous cell carcinoma chemotherapy resistance by activating PI3K/AKT signaling via targeting MRTFB[J]. Technol Cancer Res Treat, 2024, 23: 15330338241274369. DOI: 10.1177/15330338241274369. [45] Xu T, Yan Z, Lu J, et al. Long non-coding RNA NRSN2-AS1, transcribed by SOX2, promotes progression of esophageal squamous cell carcinoma by regulating the ubiquitin-degradation of PGK1[J]. Clin Exp Metastasis, 2022, 39(5): 757-769. DOI: 10.1007/s10585-022-10174-7. [46] Huang L, Wang Y, Chen J, et al. Long noncoding RNA PCAT1, a novel serum-based biomarker, enhances cell growth by sponging miR-326 in oesophageal squamous cell carcinoma [J]. Cell Death Dis, 2019, 10(7): 513. DOI: 10.1038/s41419-019-1745-4. [47] Huang T, You Q, Huang D, et al. A positive feedback between PDIA3P1 and OCT4 promotes the cancer stem cell properties of esophageal squamous cell carcinoma[J]. Cell Commun Signal, 2024, 22(1): 60. DOI: 10.1186/s12964-024-01475-3. [48] Yao GL, Pan CF, Xu H, et al. Long noncoding RNA RP11-766N7.4 functions as a tumor suppressor by regulating epithelial-mesenchymal transition in esophageal squamous cell carcinoma[J]. Biomed Pharmacother, 2017, 88: 778-785. DOI: 10.1016/j.biopha.2017.01.124. [49] Xu LJ, Yu XJ, Wei B, et al. LncRNA SNHG7 promotes the proliferation of esophageal cancer cells and inhibits its apoptosis [J]. Eur Rev Med Pharmacol Sci, 2018, 22(9): 2653-2661. DOI: 10.26355/eurrev_201805_14961. [50] Chang ZW, Jia YX, Zhang WJ, et al. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1[J]. J Exp Clin Cancer Res, 2018, 37(1): 56. DOI: 10.1186/s13046-018-0724-4. [51] Guo B, He M, Ma M, et al. Long non-coding RNA X-inactive specific transcript promotes esophageal squamous cell carcinoma progression via the microRNA 34a/Zinc finger E-box-binding homeobox 1 pathway[J]. Dig Dis Sci, 2024, 69(4):1169-1181. DOI: 10.1007/s10620-024-08269-0. [52] Sahebi R, Malakootian M, Balalaee B, et al. Linc-ROR and its spliced variants 2 and 4 are significantly up-regulated in esophageal squamous cell carcinoma[J]. Iran J Basic Med Sci, 2016, 19(10): 1131-1135. [53] Wang Z, Liu XC, Gao ZG, et al. FOXD2-AS1 is modulated by METTL3 with the assistance of YTHDF1 to affect proliferation and apoptosis in esophageal cancer[J]. Acta Pharm, 2025, 75(1): 69-86. DOI: 10.2478/acph-2025-0009. [54] Wang Z, Li K, Zhang X, et al. LINC00942 accelerates esophageal cancer progression by raising PRKDC through interaction with PTBP1[J]. J Biochem Mol Toxicol, 2025, 39(3): e70220. DOI: 10.1002/jbt.70220. [55] Xue Y, Yang R, Gong P, et al. lncRNA FENDRR predicts adverse prognosis and regulates the development of esophageal squamous cell carcinoma through negatively modulating miR-495-3p[J]. Turk J Gastroenterol, 2025, 20. DOI: 10.5152/tjg.2025.24350. [56] Tang Z, Jiang Y, Zong Y, et al. LncRNA SSTR5-AS1 promotes esophageal carcinoma through regulating ITGB6/JAK1/STAT3 signaling[J]. Epigenomics, 2024,16(17):1133-1148. DOI: 10.1080/17501911.2024.2388018. [57] Shi X, Zhang X, Huang X, et al. N6-methyladenosine-mediated upregulation of LNCAROD confers radioresistance in esophageal squamous cell carcinoma through stabilizing PARP1[J]. Clin Transl Med, 2024, 14(10):e70039. DOI: 10.1002/ctm2.70039. [58] Wu K, Wang Z, Huang Y, et al. LncRNA PTPRG-AS1 facilitates glycolysis and stemness properties of esophageal squamous cell carcinoma cells through miR-599/PDK1 axis[J]. J Gastroenterol Hepatol, 2022, 37(3):507-517. DOI: 10.1111/jgh.15719. [59] 赵舒雅,李航,樊赛军. LncRNA调控肿瘤细胞辐射敏感性作用的研究进展[J]. 国际放射医学核医学杂志,2021,45(11):701-709. DOI:10.3760/cma.j.cn121381-202101027-00116. [60] Kirkeby A, Main H, Carpenter M. Pluripotent stem-cell-derived therapies in clinical trial: a 2025 update[J]. Cell Stem Cell, 2025, 32(1):10-37. DOI: 10.1016/j.stem.2024.12.005. [61] 吴漫,刘亚萍. 长链非编码RNA在调控EMT及肿瘤侵袭转移中的作用[J]. 中国细胞生物学学报,2023,45(3):405-411. DOI:10.11844/cjcb.2023.03.0007.  | 
									
| [1] | 
														Zhao Zhou, Liu Weipeng, Li Zongrui, Wang Ruizhi, Hu Baoguang. 
														
															 Research status of hypertensive rat model [J]. International Medicine and Health Guidance News, 2025, 31(9): 1465-1470. | 
												
| [2] | 
														Zan Xingchun. 
														
															 Research progress and prospects of Tongdu Tiaoshen acupuncture in the treatment of post-stroke dysphagia [J]. International Medicine and Health Guidance News, 2025, 31(9): 1470-1474. | 
												
| [3] | 
														Li Qiang. 
														
															 Research progress of ultrasound-guided radiofrequency ablation in treatment of thyroid micropapillary carcinoma [J]. International Medicine and Health Guidance News, 2025, 31(8): 1258-1260. | 
												
| [4] | 
														Hong Jinquan, Huang Zhenyu, Huang Huiwen, Huang Haobo. 
														
															 Research progress of thymidylate synthase gene in tumorigenesis and development [J]. International Medicine and Health Guidance News, 2025, 31(8): 1260-1265. | 
												
| [5] | 
														Jiang Meng, Zhao Jingru, Liu Hui, Liu Qingxin. 
														
															 Research progress on autophagy and ischemic cerebrovascular diseases [J]. International Medicine and Health Guidance News, 2025, 31(8): 1265-1269. | 
												
| [6] | 
														Liu Hanqing, Sun Yinping, Zhao Qiang, Ren Shuai. 
														
															 Research progress on neoadjuvant immunotherapy for MSI-H/dMMR subtype patients with locally advanced colorectal cancer [J]. International Medicine and Health Guidance News, 2025, 31(8): 1270-1274. | 
												
| [7] | 
														Wen Na, Zhang Xuan. 
														
															 Mechanism of treating vulvovaginal candidiasis with Honghe Fujie liquid [J]. International Medicine and Health Guidance News, 2025, 31(8): 1292-1296. | 
												
| [8] | 
														Shi Hanjin, Ma Huixuan, Wang Yuanping. 
														
															 Mechanism of Xinkeshu in treatment of coronary heart disease based on network pharmacology and molecular docking technology [J]. International Medicine and Health Guidance News, 2025, 31(7): 1140-1148. | 
												
| [9] | 
														Zhu Peng, Tang Wenling, Qin Gang. 
														
															 Research progress on microRNA function and clinical value in colorectal cancer [J]. International Medicine and Health Guidance News, 2025, 31(6): 886-890. | 
												
| [10] | 
														Pan Wenxin, Jiang Weiwei. 
														
															 Advances in research on impact of colonoscopy timing on prognosis of patients with ischemic colitis [J]. International Medicine and Health Guidance News, 2025, 31(6): 914-917. | 
												
| [11] | 
														Zhang Ziyi, Sun Dakang. 
														
															 Research progress on mechanism of TRIM22 against HIV-1 [J]. International Medicine and Health Guidance News, 2025, 31(6): 918-922. | 
												
| [12] | 
														Yi Wei, Mi Qianqian, Zhao Jie, Li Boyu, Wang Dan. 
														
															 Application of color Doppler flow imaging in retrobulbar hemodynamic testing [J]. International Medicine and Health Guidance News, 2025, 31(6): 922-926. | 
												
| [13] | 
														Chen Xiuzhu, Zhang Kai, Wei Yanxiao, Cong Chenyang. 
														
															 Drug therapy for thyroid associated ophthalmopathy [J]. International Medicine and Health Guidance News, 2025, 31(6): 927-929. | 
												
| [14] | 
														Li Xiaotong, Yu Shengqiang. 
														
															 Research progress of tubule-derived exosomes in renal fibrosis [J]. International Medicine and Health Guidance News, 2025, 31(5): 712-718. | 
												
| [15] | 
														Zhang Han, Sun Ting, Wang Yanfei, Zhang Xiaolin, Che Juan. 
														
															 Research progress of post-transplantation lymphoproliferative disease in children with adenotonsillar hypertrophy [J]. International Medicine and Health Guidance News, 2025, 31(5): 752-757. | 
												
| Viewed | ||||||
| 
										Full text | 
									
										 | 
								|||||
| 
										Abstract | 
									
										 | 
								|||||